SkinBioTherapeutics PLC Cash Flow Quality Index
Latest as of June 2025:
-1.46x
SkinBioTherapeutics PLC cash flow quality index. SkinBioTherapeutics PLC (SBTX) has a Cash Flow Quality Index of -1.46x as of June 2025. Operating cash flow of GBX-494.84K is below net income of GBX337.85K, suggesting accrual-heavy earnings not yet converted to cash. See SBTX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-1.46x
Operating CF / Net Income
Operating Cash Flow
GBX-494.84K
GBX
Net Income
GBX337.85K
GBX
Data as of
Jun 2025
Most recent filing
SkinBioTherapeutics PLC Cash Flow Quality Index by Year (None–None)
SkinBioTherapeutics PLC cash flow quality index by year from None to None. Year-by-year earnings quality comparison for SkinBioTherapeutics PLC. For the full cash flow conversion analysis, see SkinBioTherapeutics PLC cash flow conversion.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.